Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by HighTower Advisors LLC

HighTower Advisors LLC boosted its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 89.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,666 shares of the company’s stock after purchasing an additional 14,958 shares during the period. HighTower Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $2,473,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Prestige Consumer Healthcare by 7.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,053 shares of the company’s stock valued at $863,000 after acquiring an additional 731 shares during the period. Amundi lifted its position in shares of Prestige Consumer Healthcare by 187.4% during the 4th quarter. Amundi now owns 25,669 shares of the company’s stock valued at $1,909,000 after acquiring an additional 16,737 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of Prestige Consumer Healthcare by 5.9% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,276 shares of the company’s stock valued at $412,000 after acquiring an additional 296 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $42,593,000. Finally, Proficio Capital Partners LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $1,689,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Royal Bank of Canada boosted their price target on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a report on Friday. Oppenheimer increased their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. Finally, Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price on the stock. in a report on Monday, December 9th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH opened at $84.12 on Friday. The business has a fifty day simple moving average of $82.46 and a 200-day simple moving average of $78.62. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04. The company has a market cap of $4.17 billion, a P/E ratio of 19.70, a P/E/G ratio of 2.69 and a beta of 0.46. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Insider Activity at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.